EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enhancing Cannabinoid Bioavailability in Pain Management: The Role of Cyclodextrins

Adriana Ribeiro iD, Rui Loureiro, Helena Cabral-Marques iD

Molecules · 2024

DOI: 10.3390/molecules29225340 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Adriana Ribeiro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. Hauptthemen laut MEDLINE: Cannabinoids, Biological Availability, Cyclodextrins, Pain Management. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FCT—Foundation for Science and Technology, I.P..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain (CP), including pain related to cancer, affects approximately 2 billion people worldwide, significantly diminishing quality of life and imposing socio-economic burdens. Current treatments often provide limited relief and may cause adverse effects, demanding more effective alternatives. Natural compounds from Cannabis sativa L., particularly cannabinoids like THC and CBD, exhibit analgesic and anti-inflammatory properties, but their therapeutic use is restricted by poor solubility and low bioavailability. Cyclodextrins (CDs) and cyclic oligosaccharides may encapsulate hydrophobic drugs in order to enhance their solubility and stability, offering a promising solution to these challenges. This study explores the formation of CD inclusion complexes with cannabinoids and specific terpenes, such as D-limonene (LIM), beta-caryophyllene (BCP), and gamma-terpinene (γ-TPN), aiming to improve pharmacokinetic profiles and therapeutic efficacy. We discuss analytical techniques for characterizing these complexes and their mechanisms of action, highlighting the potential of CDs to optimize drug formulations. The integration of CDs in cannabinoid therapies may enhance patient compliance and treatment outcomes in CP management. Future research should focus on innovative formulations and delivery systems to maximize the clinical applications of those compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabinoidsBiological AvailabilityCyclodextrinsPain ManagementHumansAnimalsSolubilityCannabisChronic Pain

Stichwörter der Autor:innen

Cannabisanalgesicanti-inflammatorybioavailabilitycannabinoidchronic paincyclodextrindrug deliveryinclusion complexesterpene

Substanzen

CannabinoidsCyclodextrins

Autor:innen und Institutionen

  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.

ORCID-Profile: Adriana Ribeiro, Helena Cabral-Marques

Förderung

  • FCT—Foundation for Science and Technology, I.P.

Zitieren

APA

Ribeiro, A., Loureiro, R., & Cabral-Marques, H. (2024). Enhancing Cannabinoid Bioavailability in Pain Management: The Role of Cyclodextrins. Molecules. https://doi.org/10.3390/molecules29225340

Vancouver

Ribeiro A, Loureiro R, Cabral-Marques H. Enhancing Cannabinoid Bioavailability in Pain Management: The Role of Cyclodextrins. Molecules. 2024. doi:10.3390/molecules29225340

BibTeX
@article{Ribeiro2024,
  author = {Ribeiro, Adriana and Loureiro, Rui and Cabral-Marques, Helena},
  title = {Enhancing Cannabinoid Bioavailability in Pain Management: The Role of Cyclodextrins},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29225340}
}
Kostenlos starten →